Format

Send to

Choose Destination
Clin Exp Nephrol. 2014 Apr;18(2):265-8. doi: 10.1007/s10157-013-0847-z. Epub 2013 Aug 24.

Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Author information

1
Division of Nephrology and Hypertension, University of California Irvine Medical Center, Suite 400, City Tower, 101 City Drive, Orange, CA, 92868, USA, ndvaziri@uci.edu.

Abstract

Advanced chronic kidney disease (CKD) results in a constellation of dysregulation of lipid metabolism, oxidative stress, and inflammation which are causally interconnected and participate in a vicious cycle. The CKD-associated lipid disorders are marked by impaired clearance of very low density lipoprotein and chylomicrons, hypertriglyceridemia, formation of small dense low-density lipoprotein (LDL), oxidative modification of LDL, intermediate density lipoprotein and chylomicron remnants, and high-density lipoprotein deficiency and dysfunction. This review provides a brief overview of the role of CKD-induced lipid disorders in the pathogenesis of oxidative stress, inflammation, cardiovascular disease, impaired exercise capacity, cachexia and wasting syndrome.

PMID:
23974528
DOI:
10.1007/s10157-013-0847-z
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Springer Icon for eScholarship, California Digital Library, University of California
Loading ...
Support Center